• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉生长抑制素作为肌少症肥胖早期阶段的一个合理生物标志物。

Myostatin as a plausible biomarker for early stage of sarcopenic obesity.

机构信息

Health Care Division, Health and Counseling Center, Osaka University, 1-17 Machikaneyama, Toyonaka, Osaka, 560-0043, Japan.

出版信息

Sci Rep. 2024 Nov 19;14(1):28629. doi: 10.1038/s41598-024-79534-5.

DOI:10.1038/s41598-024-79534-5
PMID:39562792
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11577097/
Abstract

Since sarcopenic obesity (SO) impacts negatively on our health, early detection of SO is essential. However, prevalence of SO in an apparently healthy population has not been well examined. This study aimed to elucidate the prevalence and related factors of SO in middle-aged women, and to investigate useful diagnostic criteria for SO. Body component analyses were conducted on 432 female Osaka University employees aged 30-59 during their health checkups. Healthy (H) and SO groups were defined using cutoff values of 5.7 kg/m for skeletal muscle mass index and 30% for percent body fat. Serum myostatin and insulin levels were additionally measured. Among 432 participants, the prevalence of SO was 6.3%. Grip strength (P < 0.0001) was lower and triglyceride (P = 0.0004) and low-density lipoprotein cholesterol (P = 0.0105) levels, and Homeostatic Model Assessment of Insulin Resistance (P = 0.0262) were higher in the SO group than in the H group. Serum myostatin levels in the SO group were lower than in the H group (3,107 pg/mL vs. 3,957 pg/mL, P = 0.0003). Myostatin levels may be suppressed in individuals with SO without any pre-existing conditions. Our diagnostic criteria for SO could reveal the risks for metabolic-related diseases and may be useful for the early detection of SO.

摘要

由于肌少症合并肥胖(SO)对健康有负面影响,因此早期发现 SO 至关重要。然而,目前尚未充分研究在健康人群中 SO 的流行情况。本研究旨在阐明中年女性中 SO 的流行情况及其相关因素,并探讨 SO 的有用诊断标准。在健康检查期间,对大阪大学的 432 名 30-59 岁的女性员工进行了身体成分分析。使用骨骼肌质量指数的 5.7 kg/m2 和体脂肪百分比的 30%作为截断值,将健康(H)和 SO 组定义为。此外,还测量了血清肌肉生长抑制素和胰岛素水平。在 432 名参与者中,SO 的患病率为 6.3%。与 H 组相比,SO 组的握力(P<0.0001)较低,甘油三酯(P=0.0004)和低密度脂蛋白胆固醇(P=0.0105)水平较高,胰岛素抵抗的稳态模型评估(P=0.0262)较高。SO 组的血清肌肉生长抑制素水平低于 H 组(3107 pg/mL 比 3957 pg/mL,P=0.0003)。可能是没有任何预先存在的疾病的情况下,SO 个体的肌肉生长抑制素水平被抑制。我们的 SO 诊断标准可以揭示与代谢相关疾病的风险,并且可能有助于早期发现 SO。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a435/11577097/3b2072211b06/41598_2024_79534_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a435/11577097/ad125d39a599/41598_2024_79534_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a435/11577097/c70a7b492281/41598_2024_79534_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a435/11577097/3b2072211b06/41598_2024_79534_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a435/11577097/ad125d39a599/41598_2024_79534_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a435/11577097/c70a7b492281/41598_2024_79534_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a435/11577097/3b2072211b06/41598_2024_79534_Fig3_HTML.jpg

相似文献

1
Myostatin as a plausible biomarker for early stage of sarcopenic obesity.肌肉生长抑制素作为肌少症肥胖早期阶段的一个合理生物标志物。
Sci Rep. 2024 Nov 19;14(1):28629. doi: 10.1038/s41598-024-79534-5.
2
Circulating myostatin as a biomarker of muscle mass and strength in individuals with cancer or obesity.循环肌生成抑制素作为癌症或肥胖个体肌肉量和肌肉力量的生物标志物。
Clin Nutr. 2024 Jul;43(7):1800-1808. doi: 10.1016/j.clnu.2024.05.046. Epub 2024 May 31.
3
Irisin is a predictor of sarcopenic obesity in type 2 diabetes mellitus: A cross-sectional study.鸢尾素是 2 型糖尿病患者合并肌少症性肥胖的预测因子:一项横断面研究。
Medicine (Baltimore). 2021 Jul 2;100(26):e26529. doi: 10.1097/MD.0000000000026529.
4
Myostatin in combination with creatine phosphokinase or albumin may differentiate patients with cirrhosis and sarcopenia.肌抑素联合肌酸磷酸激酶或白蛋白可能有助于鉴别肝硬化伴肌少症患者。
Am J Physiol Gastrointest Liver Physiol. 2021 Nov 1;321(5):G543-G551. doi: 10.1152/ajpgi.00184.2021. Epub 2021 Sep 1.
5
Healthy community-living older men differ from women in associations between myostatin levels and skeletal muscle mass.健康的社区生活老年男性与女性在肌肉生长抑制素水平和骨骼肌质量之间的关联存在差异。
J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):635-642. doi: 10.1002/jcsm.12302. Epub 2018 Apr 13.
6
Serum Myostatin and IGF-1 as Gender-Specific Biomarkers of Frailty and Low Muscle Mass in Community-Dwelling Older Adults.血清肌生成抑制素和 IGF-1 作为社区居住的老年人群中衰弱和低肌肉量的性别特异性生物标志物。
J Nutr Health Aging. 2019;23(10):979-986. doi: 10.1007/s12603-019-1255-1.
7
Association of serum adiponectin and myostatin levels with skeletal muscle in patients with obesity: A cross-sectional study.血清脂联素和肌肉生长抑制素水平与肥胖患者骨骼肌的相关性:一项横断面研究。
PLoS One. 2021 Jan 19;16(1):e0245678. doi: 10.1371/journal.pone.0245678. eCollection 2021.
8
Serum concentrations of insulin-like growth factor-1, members of the TGF-beta superfamily and follistatin do not reflect different stages of dynapenia and sarcopenia in elderly women.老年女性血清中胰岛素样生长因子-1、转化生长因子-β超家族成员和卵泡抑素的浓度并不能反映肌肉减少症和肌无力的不同阶段。
Exp Gerontol. 2015 Apr;64:35-45. doi: 10.1016/j.exger.2015.02.008. Epub 2015 Feb 12.
9
The Vicious Cycle of Myostatin Signaling in Sarcopenic Obesity: Myostatin Role in Skeletal Muscle Growth, Insulin Signaling and Implications for Clinical Trials.肌少症性肥胖中肌肉生长抑制素信号传导的恶性循环:肌肉生长抑制素在骨骼肌生长、胰岛素信号传导中的作用及对临床试验的影响
J Frailty Aging. 2018;7(1):21-27. doi: 10.14283/jfa.2017.33.
10
The Prevalence Rate of Adult Sarcopenic Obesity and Correlation of Appendicular Skeletal Muscle Mass Index with Body Mass Index, Percent Body Fat, Waist-Hip Ratio, Basal Metabolic Rate, and Visceral Fat Area.成人肌少性肥胖的患病率以及四肢骨骼肌质量指数与体重指数、体脂百分比、腰臀比、基础代谢率和内脏脂肪面积的相关性。
Metab Syndr Relat Disord. 2023 Feb;21(1):48-56. doi: 10.1089/met.2022.0035. Epub 2022 Nov 1.

本文引用的文献

1
Mechanisms of myostatin and activin A accumulation in chronic kidney disease.慢性肾脏病中肌肉生长抑制素和激活素 A 蓄积的机制。
Nephrol Dial Transplant. 2022 Jun 23;37(7):1249-1260. doi: 10.1093/ndt/gfac136.
2
Myostatin serum levels in children with type 1 diabetes mellitus.1 型糖尿病患儿血清肌肉抑制素水平。
Hormones (Athens). 2021 Dec;20(4):777-782. doi: 10.1007/s42000-021-00317-y. Epub 2021 Sep 6.
3
Myostatin in combination with creatine phosphokinase or albumin may differentiate patients with cirrhosis and sarcopenia.
肌抑素联合肌酸磷酸激酶或白蛋白可能有助于鉴别肝硬化伴肌少症患者。
Am J Physiol Gastrointest Liver Physiol. 2021 Nov 1;321(5):G543-G551. doi: 10.1152/ajpgi.00184.2021. Epub 2021 Sep 1.
4
The Relevance of Diet, Physical Activity, Exercise, and Persuasive Technology in the Prevention and Treatment of Sarcopenic Obesity in Older Adults.饮食、身体活动、运动及劝导技术在老年人肌少症性肥胖预防和治疗中的相关性
Front Nutr. 2021 May 24;8:661449. doi: 10.3389/fnut.2021.661449. eCollection 2021.
5
Obesity Measures and Definitions of Sarcopenic Obesity in Singaporean Adults - the Yishun Study.新加坡成年人肥胖测量和肌少性肥胖定义 - 义顺研究。
J Frailty Aging. 2021;10(3):202-210. doi: 10.14283/jfa.2020.65.
6
The Association Between Sarcopenic Obesity and Hypertension, Diabetes, and Abnormal Lipid Metabolism in Chinese Adults.中国成年人肌少症肥胖与高血压、糖尿病及脂质代谢异常之间的关联
Diabetes Metab Syndr Obes. 2021 Apr 30;14:1963-1973. doi: 10.2147/DMSO.S308387. eCollection 2021.
7
Targeting the myostatin signaling pathway to treat muscle loss and metabolic dysfunction.靶向肌生成抑制素信号通路治疗肌肉减少症和代谢功能障碍。
J Clin Invest. 2021 May 3;131(9). doi: 10.1172/JCI148372.
8
Associations between different measurements of sarcopenic obesity and health outcomes among non-frail community-dwelling older adults in Taiwan.台湾非虚弱社区居住老年人中不同骨骼肌肥胖测量指标与健康结果的相关性。
Br J Nutr. 2021 Dec 14;126(11):1749-1757. doi: 10.1017/S0007114521001288. Epub 2021 Apr 14.
9
Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions.脂肪细胞因子、肌细胞因子和肝细胞因子:串扰和代谢后果。
Int J Mol Sci. 2021 Mar 5;22(5):2639. doi: 10.3390/ijms22052639.
10
Association of serum adiponectin and myostatin levels with skeletal muscle in patients with obesity: A cross-sectional study.血清脂联素和肌肉生长抑制素水平与肥胖患者骨骼肌的相关性:一项横断面研究。
PLoS One. 2021 Jan 19;16(1):e0245678. doi: 10.1371/journal.pone.0245678. eCollection 2021.